Unlock stock picks and a broker-level newsfeed that powers Wall Street.

LRCX vs. ACMR: Which Semiconductor Equipment Stock is the Better Buy?

In This Article:

Lam Research LRCX and ACM Research ACMR are both deeply embedded in the semiconductor manufacturing supply chain, but they operate at very different scales and strategic exposures. The global chip industry reaccelerates due to artificial intelligence (AI) and high-performance computing demand, which will aid the prospects of these equipment providers.

However, while Lam Research is a mature powerhouse, ACM Research is a fast-growing upstart capitalizing on China’s semiconductor boom. So, the question arises: Which stock offers better value and long-term growth potential today?

The Case for Lam Research Stock

Lam Research has long been a pillar of the chip equipment world, especially in etch and deposition technology, which are critical for producing high-bandwidth memory (HBM) and advanced packaging technologies essential for AI workloads. These leading-edge technologies are helping it capitalize on the opportunities from the booming demand for AI and datacenter chips, which require advanced fabrication technologies.

In 2024, Lam Research’s shipments for gate-all-around nodes and advanced packaging exceeded $1 billion, and management expects this figure to triple to more than $3 billion by 2025. Additionally, the industry’s migration to backside power distribution and dry-resist processing presents further growth opportunities for Lam Research’s cutting-edge fabrication solutions.

These trends are aiding Lam Research’s financial performance. In the second quarter of fiscal 2025, the company reported revenues of $4.38 billion, up 16.4% year over year, and earnings per share (EPS) of 91 cents, highlighting a 21% increase (adjusting for stock split). The Zacks Consensus Estimate for fiscal 2025 signals continued stability in its core business. The consensus mark for revenues and EPS indicates year-over-year growth of 18.8% and 24.8%, respectively.

Nonetheless, Lam Research is not immune to risks. U.S.-China trade tensions pose a significant challenge. China accounted for 31% of its second-quarter fiscal 2025 revenues, down from 37% in the prior quarter. During the last reported quarter earnings call, the company revealed that $700 million in expected sales from restricted Chinese customers will not materialize in 2025, creating a noticeable sales gap.

Additionally, declining demand for mature-node semiconductor equipment is weighing on Lam Research’s foundry business. Foundry revenues fell from 41% of system sales in the first quarter to 35% in the second quarter, reflecting weaker demand. With TSMC and other foundries slowing their mature-node spending, Lam Research’s growth in this segment could remain sluggish.